# FDA Inspection 1166549 - ALS Group USA Corp - March 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/als-group-usa-corp/42cc3414-7aee-4269-9e30-4f4c1fda0ab3
Source feed: FDA_Inspections

> FDA Inspection 1166549 for ALS Group USA Corp on March 23, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166549
- Company Name: ALS Group USA Corp
- Inspection Date: 2022-03-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1009089 - 2017-02-06](https://www.keypedia.com/records/fda_inspections/als-group-usa-corp/a806e824-bff0-4b4f-b486-ca14d59242ee)

Company: https://www.keypedia.com/companies/als-group-usa-corp/a93e7a21-307e-4605-ac30-f2de873a8116

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c